"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 7 | 7 |
| 1996 | 0 | 8 | 8 |
| 1997 | 0 | 12 | 12 |
| 1998 | 0 | 12 | 12 |
| 1999 | 0 | 12 | 12 |
| 2000 | 0 | 6 | 6 |
| 2001 | 0 | 8 | 8 |
| 2002 | 0 | 13 | 13 |
| 2003 | 0 | 17 | 17 |
| 2004 | 0 | 10 | 10 |
| 2005 | 0 | 10 | 10 |
| 2006 | 0 | 14 | 14 |
| 2007 | 0 | 16 | 16 |
| 2008 | 0 | 14 | 14 |
| 2009 | 0 | 13 | 13 |
| 2010 | 0 | 18 | 18 |
| 2011 | 0 | 20 | 20 |
| 2012 | 0 | 17 | 17 |
| 2013 | 0 | 12 | 12 |
| 2014 | 1 | 19 | 20 |
| 2015 | 0 | 20 | 20 |
| 2016 | 0 | 21 | 21 |
| 2017 | 0 | 12 | 12 |
| 2018 | 0 | 27 | 27 |
| 2019 | 0 | 20 | 20 |
| 2020 | 0 | 27 | 27 |
| 2021 | 0 | 25 | 25 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 19 | 19 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins). J Manag Care Spec Pharm. 2025 Apr; 31(4):396-405.
-
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2025 Mar 17; 31(6):965-974.
-
Infant and Toddler Peanut Oral Immunotherapy: Initiation Before Age 2 Increases Ad Libitum Peanut Consumption. J Allergy Clin Immunol Pract. 2025 Apr; 13(4):885-892.
-
Newer formulations of oral testosterone undecanoate: development and liver side effects. Sex Med Rev. 2025 Jan 31; 13(1):33-40.
-
Geographic disparities impacting oral vaccine performance: Observations and future directions. Clin Exp Immunol. 2025 Jan 21; 219(1).
-
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study. Clin Cancer Res. 2024 Dec 02; 30(23):5304-5313.
-
Outcomes Associated With Novel Oral Anticoagulants and Warfarin in Patients With Cardiac Thrombus Following ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2025 Feb 01; 236:72-78.
-
The impact of electronic cigarette aerosol exposure on spatial memory formation: Modulation by orally administered vitamin E. Neurotoxicology. 2024 Dec; 105:263-271.
-
Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes. Pediatr Diabetes. 2024; 2024:8343868.
-
Direct Oral Anticoagulants for Rheumatic?Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC Clin Electrophysiol. 2024 Dec; 10(12):2701-2710.